These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 35729111)

  • 41. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris.
    Bruno M; Kersten S; Bain JM; Jaeger M; Rosati D; Kruppa MD; Lowman DW; Rice PJ; Graves B; Ma Z; Jiao YN; Chowdhary A; Renieris G; van de Veerdonk FL; Kullberg BJ; Giamarellos-Bourboulis EJ; Hoischen A; Gow NAR; Brown AJP; Meis JF; Williams DL; Netea MG
    Nat Microbiol; 2020 Dec; 5(12):1516-1531. PubMed ID: 32839538
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What do we know about the biology of the emerging fungal pathogen of humans Candida auris?
    Bravo Ruiz G; Lorenz A
    Microbiol Res; 2021 Jan; 242():126621. PubMed ID: 33096325
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
    J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
    [No Abstract]   [Full Text] [Related]  

  • 46. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation.
    Ajetunmobi OH; Chaturvedi AK; Badali H; Vaccaro A; Najvar L; Wormley FL; Wiederhold NP; Patterson TF; Lopez-Ribot JL
    APMIS; 2023 Nov; 131(11):613-625. PubMed ID: 37337909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uniqueness of Candida auris cell wall in morphogenesis, virulence, resistance, and immune evasion.
    Dakalbab S; Hamdy R; Holigová P; Abuzaid EJ; Abu-Qiyas A; Lashine Y; Mohammad MG; Soliman SSM
    Microbiol Res; 2024 Sep; 286():127797. PubMed ID: 38851008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leveraging the MMV Pathogen Box to Engineer an Antifungal Compound with Improved Efficacy and Selectivity against
    Pan B; Weerasinghe H; Sezmis A; McDonald MJ; Traven A; Thompson P; Simm C
    ACS Infect Dis; 2023 Oct; 9(10):1901-1917. PubMed ID: 37756147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host defense mechanisms against
    Pechacek J; Lionakis MS
    Expert Rev Anti Infect Ther; 2023; 21(10):1087-1096. PubMed ID: 37753840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of a new chemical scaffold for the treatment of superbug
    Tu J; Zhu T; Wang Q; Yang W; Huang Y; Xu D; Liu N; Sheng C
    Emerg Microbes Infect; 2023 Dec; 12(1):2208687. PubMed ID: 37102336
    [No Abstract]   [Full Text] [Related]  

  • 52. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
    Dekkerová J; Lopez-Ribot JL; Bujdáková H
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Candida auris Mannans and Pathogen-Host Interplay.
    Chaturvedi V; Linhardt RJ; Papon N
    Trends Microbiol; 2020 Dec; 28(12):954-956. PubMed ID: 33190684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
    Sherry L; Ramage G; Kean R; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R
    Emerg Infect Dis; 2017 Feb; 23(2):328-331. PubMed ID: 28098553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A decade after the emergence of Candida auris: what do we know?
    ElBaradei A
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1617-1627. PubMed ID: 32297040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First report of sporadic cases of Candida auris in Colombia.
    Parra-Giraldo CM; Valderrama SL; Cortes-Fraile G; Garzón JR; Ariza BE; Morio F; Linares-Linares MY; Ceballos-Garzón A; de la Hoz A; Hernandez C; Alvarez-Moreno C; Le Pape P
    Int J Infect Dis; 2018 Apr; 69():63-67. PubMed ID: 29421668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candida auris on Apples: Diversity and Clinical Significance.
    Yadav A; Jain K; Wang Y; Pawar K; Kaur H; Sharma KK; Tripathy V; Singh A; Xu J; Chowdhary A
    mBio; 2022 Apr; 13(2):e0051822. PubMed ID: 35357170
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Miramón P; Pountain AW; Lorenz MC
    Infect Immun; 2023 Nov; 91(11):e0027423. PubMed ID: 37815367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging strategies for environmental decontamination of the nosocomial fungal pathogen
    Bandara HMHN; Samaranayake LP
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35687657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.